Cefixime is an orally active third generation bactericidal cephalosporin with broad spectrum of coverage
Cefixime has been shown to be active against most strains of the Gram-positive organisms. As with other cephalosporins, bactericidal action of cefixime results from inhibition of bacterial cell- wall synthesis. Cefixime is highly stable in the presence of betalactamase enzymes.
Ofloxacin is a synthetic fluoroquinolone drug class considered to be a second-generation fluoroquinolone. Ofloxacin is an Broad spectrum bactericidal which inhibits the enzyme Bacterial DNA gyrase.
Ofloxacin is used to treat pneumonia and bronchitis caused by Haemophilus influenzae and Streptococcus pneumoniae. It is also used in treating skin infections caused by staphylococcus aureus, and streptococcus pyogenes . Ofloxacin is often used to treat urinary infections and prostate infections caused by E. coli.
This is a combination of Cefixime (cephalosporin) and Ofloxacin (fluoroquinolone) and has unique dual mode of action. Ofloxacin prevents nucleic acid synthesis of bacteria and Cefixime inhibits bacterial cell wall synthesis. Both work instantly and synergistically and gives prompt results.
- Typhoid Fever
- Urinary Tract Infection
- Respiratory Tract Infection
- Nosocomial Infections
- Soft Tissue Infections
- Surgical Prophylaxis
- Intra-abdominal Infections
- Skin and soft tissue infections
- Bone and joint infections
One tablet b i d for 7 to 14 days depending on the severity of infection
Alu-Alu strip of 10 tablets. 10 strips in a box